Table 1 Clinicopathological variables of patients with breast cancer containing signet ring cells
Case | Age | Tumor site | Histological type | Tumor size (cm) | Nuclear grade | SRC population (%) | SRC type | LN status | LVI | Recurrence | Follow-up (months) | Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 57 | R-UOQ | IDC | 2.1 | 3 | 18 | Non-ICL | + | + | − | 137 | Alive |
2 | 42 | L-UOQ | IDC | 3 | 1 | 30 | Non-ICL | + | + | − | 108 | Alive |
3 | 45 | L-LIQ | IDC | 5 | 3 | 80 | Non-ICL | + | + | + liver | 66 | Dead |
4 | 72 | R-UOQ | IDC | 2.8 | 2 | 21 | Non-ICL | − | − | − | 67 | Alive |
5 | 74 | R-UOQ | IDC | 2.2 | 1 | 39 | ICL | − | − | − | 30 | Alive |
6 | 64 | R-UOQ | IDC | 2.7 | 1 | 30 | Non-ICL | + | + | − | 12 | Alive |
7 | 65 | R-UOQ | IDC | 0.7 | 1 | 55 | ICL | + | − | − | 45 | Alive |
8 | 48 | R-LIQ | IDC | 2.1 | 2 | 79 | Non-ICL | − | − | − | 12 | Alive |
9 | 78 | L-LOQ | IDC | 1.2 | 1 | 81 | Non-ICL | − | − | − | 12 | Alive |
10 | 85 | L-IQT | ILC | 3.5 | 1 | 35 | ICL | − | − | − | 50 | Alive |
11 | 62 | R-OQT | ILC | 6.8 | 2 | 73 | ICL | − | − | − | 64 | Alive |
12 | 80 | R-UOQ | ILC | 3.1 | 2 | 22 | ICL | + | + | + brain | 31 | Dead |
13 | 57 | R-UOQ | ILC | 1.8 | 1 | 8 | Non-ICL | − | − | − | 74 | Alive |
14 | 47 | L-UOQ | ILC | 2.8 | 1 | 62 | Non-ICL | + | + | − | 72 | Alive |
15 | 55 | R-OQT | ILC | 2 | 1 | 19 | ICL | − | + | − | 20 | Alive |
16 | 76 | R-UOQ | ILC | 1.2 | 3 | 20 | Non-ICL | + | − | − | 14 | Alive |
17 | 52 | R-LOQ | ILC | 1 | 1 | 28 | ICL | − | − | − | 12 | Alive |
18 | 76 | L-UQT | ILC | 1.8 | 1 | 47 | ICL | − | − | − | 12 | Alive |
19 | 78 | R-OQT | MC | 1.5 | 1 | 14 | Non-ICL | − | − | − | 125 | Alive |
20 | 63 | R-LOQ | MC | 0.7 | 1 | 65 | Non-ICL | − | − | − | 79 | Alive |
21 | 66 | L-UOQ | MC | 1.5 | 1 | 62 | Non-ICL | − | − | − | 35 | Alive |
22 | 68 | R-OQT | MC | 2.5 | 2 | 42 | Non-ICL | − | − | − | 16 | Alive |